We determined the sequence, specificity for structurally related carde
nolides, and three-dimensional. structure of the anti-digoxin antibody
40-50 Fab in complex with ouabain. The 40-50 antibody does not share
close sequence homology with other high-affinity anti-digoxin antibodi
es. Measurement of the binding constants of structurally distinct digo
xin analogs indicated a well-defined specificity pattern also distinct
from other anti-digoxin antibodies. The 40-50-ouabain Fab complex cry
stallizes in space group C2 with cell dimensions of a = 93.7 Angstrom,
b = 84.8 Angstrom, c = 70.1 Angstrom, beta = 128.0 degrees. The struc
ture of the complex was determined by X-ray crystallography and refine
d at a resolution of 2.7 Angstrom. The hapten is bound in a pocket ext
ending as a groove from the center of the combining site across the li
ght chain variable domain, with five of the six complementarity-determ
ining regions involved in interactions with the hapten. Approximately
three-quarters of the hapten surface area is buried in the complex; tw
o hydrogen bonds are formed between the antibody and hapten. The surfa
ce area of the antibody combining site buried by ouabain is contribute
d equally by the Light and heavy chain variable domains. Over half of
the surface area buried on the Fab consists of the aromatic side-chain
s. The surface complementarity between hapten and antibody is sufficie
nt to make the complex specific for only one lactone ring conformation
in the hapten. The crystal structure of the 40-50-ouabain complex all
ows qualitative explanation of the observed fine specificities of 40-5
0, including that for the binding of haptens substituted at the 16 and
12 positions. Comparison of the crystal structures of 40-50 complexed
with ouabain and the previously determined 26-10 anti-digoxin Fab com
plexed with digoxin, demonstrates that the antibodies bind these struc
turally related haptens in different orientations, consistent with the
ir different fine specificities. These results demonstrate that the im
mune system can generate antibodies that provide diverse structural so
lutions to the binding of even small molecules.